Inpixon amends warrants, issues ~2M shares to retire ~$400K debt

XTI Aerospace, Inc.

Amendment grants warrant holders 20% pro-rata participation rights in future equity offerings for 12 months.
Registration statement filing deadline extended to 45 days; warrant exercise price floor set at $0.10.
Issued 1,995,573 shares at ~$0.20/share to reduce promissory note by ~$400,000.
After issuance, total shares outstanding: 40,296,799.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

XTI Aerospace, Inc. amended Amendment to Warrant Purchase Agreement and Warrants with holders of Common Stock Purchase Warrants valued at Amendment granting participation rights, extended registration period, and adjusted warrant terms (effective 2023-06-20).

Action: amendment
Agreement: equity purchase
Counterparty: holders of Common Stock Purchase Warrants
Value: Amendment granting participation rights, extended registration period, and adjusted warrant terms
Effective: 2023-06-20

Exact text from the filing

On June 20, 2023, Inpixon (the “Company”) entered into an amendment agreement (the “Amendment”) with the holders (each, including its successors and assigns, a “Holder” and collectively, the “Holders”) of the Common Stock Purchase Warrants issued by the Company on May 17, 2023 (as amended from time to time in accordance with their terms, the “Warrants”) pursuant to the terms and conditions of that certain Warrant Purchase Agreement, dated May 15, 2023, by and among the Company and the Holders (as amended from time to time in accordance with its terms, the “Purchase Agreement”).

View on SEC.gov

Browse all material agreements →

XTI Aerospace, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-050619

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.